• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Catalog Number ETBF2813C145E
Medical Device Problem Codes Leak/Splash (1354); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Rupture (2208); Obstruction/Occlusion (2422)
Date of Event 05/11/2026
Type of Reportable Event Death
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
An endurant ii stent graft system was implanted during the endovascular treatment of a 50 mm aneurysm.It was reported that the patient presented emergently 9.5 years later with a ruptured aneurysm.It was noted that the patient had a fall at their home 3 days before.Total occlusion of the right iliac limb, noted as the ipsilateral limb of the bifurcate was also identified on the ct scan.An endoleak was identified and was suspected to be a type iii fabric endoleak.A 28 aui stent graft was then implanted via the left side but the endoleak was still present.The physician attempted to access the right limb by cutting down on the common femoral but were unable to pass a wire up the limb so no they could not perform any treatment to restore flow.The pre-operative cta performed showed the right limb totally occluded , however, there was some flow into the right limb observed during the procedural angiogram.It was reported that the patient expired on the same day.According to the physician, the cause of death was attributed to the type iii endoleak following trauma.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II BIFURCATED STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key25268466
Report Number9612164-2026-02678
Device Sequence Number13187627
Product Code MIH
UDI-Device Identifier00613994991294
UDI-Public(01)00613994991294(17)180913
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/25/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/13/2018
Device Catalogue NumberETBF2813C145E
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/11/2026
Initial Report FDA Received Date05/25/2026
Date Device Manufactured09/13/2016
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Death;
Patient Age78 YR
Patient SexFemale
-
-